Prudential Financial’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,468
Closed -$291K 2635
2021
Q4
$291K Buy
6,468
+153
+2% +$6.16K ﹤0.01% 2408
2021
Q3
$297K Buy
+6,315
New +$229K ﹤0.01% 2328
2021
Q2
Sell
-5,614
Closed -$219K 2584
2021
Q1
$219K Buy
+5,614
New +$252K ﹤0.01% 2377
2020
Q4
Sell
-26,566
Closed -$1.48M 2473
2020
Q3
$1.48M Buy
+26,566
New +$1.41M ﹤0.01% 1462

Other funds holding GDRX

Prudential Financial's GDRX Position: Q1 2022 in Review

Prudential Financial sold out of GoodRx Holdings (GDRX) in Q1 2022, closing a stake of 6,468 shares — an estimated $291K sold.

Prudential Financial first reported a position in GDRX in Q3 2020 and held it in 4 quarters. The position peaked at $1.48M in Q3 2020. 167 funds tracked by Wall St. Rank hold GDRX as of Q1 2022.

  • Prudential Financial reported no remaining GoodRx Holdings position as of Q1 2022 after selling out during the quarter.
  • Prudential Financial sold 6,468 GoodRx Holdings shares in Q1 2022, an estimated $291K.
  • Prudential Financial first reported a position in GoodRx Holdings in Q3 2020 and held it in 4 quarters.
  • Prudential Financial's GoodRx Holdings position peaked at $1.48M in Q3 2020.
  • 167 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2022.

Based on Prudential Financial's 13F filing for Q1 2022, filed 13 May 2022.